KALA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR DEFERRED RESTRICTED STOCK UNIT AWARDDeferred Restricted Stock Unit Award • May 7th, 2020 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Kala Pharmaceuticals, Inc. (the “Company”) hereby grants the following Deferred Restricted Stock Units pursuant to its 2017 Equity Incentive Plan (the “Plan”). The terms of the grant are set forth in the attached Restricted Stock Unit Award Agreement (the “Agreement”).
KALA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AWARDRestricted Stock Unit Award • May 7th, 2020 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Kala Pharmaceuticals, Inc. (the “Company”) hereby grants the following Restricted Stock Units pursuant to its 2017 Equity Incentive Plan (the “Plan”). The terms of the grant are set forth in the attached Restricted Stock Unit Award Agreement (the “Agreement”).
AMENDMENT #2Commercial Supply Agreement • May 7th, 2020 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations
This SECOND AMENDMENT (“Second Amendment”) is made and entered into effective as of March 27, 2020 (“Second Amendment Effective Date”), by and between and between Kala Pharmaceuticals, Inc., a Delaware corporation, with a place of business at 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, USA (“Client”), and Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873, USA (“Catalent”). Each of Client and Catalent may be referred to as a Party, and collectively as the Parties.
